Joanna Grudzinska

Joanna Grudzinska

Company: Bayer AG

Job title: Drug Metabolism & Pharmacokinetics Project Manager


Immunogenicity Risk Assessment of mRNA/LNP Therapies 9:30 am

Outlining the importance of the immunogenicity risk assessment for the development of safe mRNA/LNP therapies Summarizing regulatory requirements and providing practical guidance on immunogenicity risk identification and evaluation Emphasizing the impact of immunogenicity risk assessment on the bioanalytical monitoring strategy for all mRNA/LNP components during developmentRead more

day: Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.